Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Non Operating Income (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Non Operating Income readings, the most recent being -$3.6 million for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 704.01% to -$3.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$13.0 million, a 279.34% decrease, with the full-year FY2025 number at -$13.0 million, down 279.34% from a year prior.
  • Non Operating Income hit -$3.6 million in Q4 2025 for Tandem Diabetes Care, down from -$2.3 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $4.2 million in Q1 2023 to a low of -$5.9 million in Q2 2025.
  • Median Non Operating Income over the past 5 years was -$283500.0 (2022), compared with a mean of $23100.0.
  • Biggest five-year swings in Non Operating Income: surged 687.76% in 2023 and later crashed 704.01% in 2025.
  • Tandem Diabetes Care's Non Operating Income stood at -$1.6 million in 2021, then skyrocketed by 204.46% to $1.7 million in 2022, then skyrocketed by 125.36% to $3.8 million in 2023, then tumbled by 84.05% to $598000.0 in 2024, then plummeted by 704.01% to -$3.6 million in 2025.
  • The last three reported values for Non Operating Income were -$3.6 million (Q4 2025), -$2.3 million (Q3 2025), and -$5.9 million (Q2 2025) per Business Quant data.